ZURICH, Oct 4 (Reuters) – Roche said on Tuesday its
lung cancer drug Alecensa (alectinib), developed by its
Genentech unit, received a second breakthrough therapy
designation (BTD) from the U.S. Food…
The post Roche say cancer drug Alecensa gets breakthrough therapy designation appeared first on NASDAQ.